DGAP-Adhoc: BB Biotech AG publishes its 2021 annual report
DGAP-Ad-hoc: BB Biotech AG / Key word(s): Annual Report BB Biotech AG publishes its 2021 annual report 18-Feb-2022 / 08:05 CET/CEST Disclosu...
Stay updated with breaking news from Ute Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-Ad-hoc: BB Biotech AG / Key word(s): Annual Report BB Biotech AG publishes its 2021 annual report 18-Feb-2022 / 08:05 CET/CEST Disclosu...
DGAP-News: BB Biotech AG / Key word(s): Annual Results/Dividend BB BIOTECH AG: 2021 was a difficult year for biotech equity markets -...
DGAP-News: BB Biotech AG / Key word(s): Annual Results/Dividend BB BIOTECH AG: 2021 was a difficult year for biotech equity markets -...
Investegate announcements from BB BIOTECH AG, BB Biotech: Gains realized following COVID-19 vaccine booster update enable increases in oncology and CNS
Nachricht vom 23.07.2021 | 07:00 Solid second quarter for the biotech industry - BB Biotech raised its allocation to promising small and mid caps DGAP-News: BB BIOTECH AG / Key word(s): Half Year Report/Interim Report 23.07.2021 / 07:00 Media release of July 23, 2021 Interim report of BB Biotech AG as at June 30, 2021 Solid second quarter for the biotech industry - BB Biotech raised its allocation to promising small and mid caps Inflation moved higher during the second quarter as the economic recovery gathered steam, triggering temporary outflows of investor capital from growth sectors....